Patents by Inventor Thomas Baumruker

Thomas Baumruker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of EDG Receptor Binding Agents in Cancer
    Publication number: 20140303257
    Abstract: Provided is a method for treating solid tumors, e.g tumor invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1-phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent.
    Type: Application
    Filed: June 23, 2014
    Publication date: October 9, 2014
    Applicant: Novartis AG
    Inventors: Thomas Baumruker, Volker Brinkmann, Kenneth Richard La Montagne, Peter T. Lassota, Diane Mechtcheriakova, Jeanette Majorie Wood
  • USE OF EDG RECEPTOR BINDING AGENTS IN CANCER
    Publication number: 20090209495
    Abstract: Provided is a method for treating solid tumors, e.g. tumor invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1-phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent.
    Type: Application
    Filed: April 9, 2009
    Publication date: August 20, 2009
    Inventors: Thomas Baumruker, Volker Brinkmann, Kenneth Richard La Montagne, Peter T. Lassota, Diana Mechtcheriakova, Jeanette Marjorie Wood
  • BIOMARKER IN INFLAMMATORY DISEASES
    Publication number: 20080145883
    Abstract: The use of SPP2 as a target in inflammatory responses, e.g. as a biomarker, e.g. for immune disorders associated with inflammation, such as psoriasis; diagnostic kits comprising means for determining the level of SPP2 and a method for identifying agents that modulates SPP2 activity.
    Type: Application
    Filed: October 3, 2007
    Publication date: June 19, 2008
    Inventors: Thomas Baumruker, Andreas Billich, Diana Mechtcheriakova, Alexander Wlachos
  • 2-amino-propanol derivatives
    Patent number: 7326801
    Abstract: Compounds of formula I wherein m, R, R1 and R3 to R6 are as defined in the specification, m, is 1, 2 or 3 and X is O or a direct bond, and the corresponding unphosporylated compounds have interesting properties, e.g. immunosuppressive properties.
    Type: Grant
    Filed: March 26, 2002
    Date of Patent: February 5, 2008
    Assignee: Novartis AG
    Inventors: Rainer Albert, Thomas Baumruker, Volker Brinkmann, Sylvain Cottens, Klaus Hinterding, Christos Papageorgiou, Eva Erika Prieschl-Strassmayr
  • Use of edg receptor binding agents in cancer
    Publication number: 20050215531
    Abstract: Provided is a method for treating solid tumors, e.g. tumor invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1-phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent.
    Type: Application
    Filed: May 15, 2003
    Publication date: September 29, 2005
    Inventors: Thomas Baumruker, Volker Brinkmann, Kenneth La Montagne, Peter Lassota, Diana Mechtcheriakova, Jean Wood
  • FcyrIII signaling inhibitor assay
    Publication number: 20050181457
    Abstract: The present invention provides an assay and its use for identifying agents that inhibit the Fc?RIII signaling.
    Type: Application
    Filed: May 16, 2003
    Publication date: August 18, 2005
    Inventors: Thomas Baumruker, Eva Prieschl
  • 2-Amino-propanol derivatives
    Publication number: 20040147490
    Abstract: Compounds of formula (i), wherein m, R, R1, and R3 to R6 are as defined in the specification, m, is 1, 2 or 3 and X is O or a direct bond, and the corresponding unphosporylated compounds have interesting properties, e.g. immunosuppressive properties.
    Type: Application
    Filed: March 18, 2004
    Publication date: July 29, 2004
    Inventors: Rainer Albert, Thomas Baumruker, Volker Brinkmann, Sylvain Cottens, Klaus Hinterding, Christos Papageorgiou, Eva Erika Prieschl-Strassmayr